GTCR Pharma Platform Adds On

Actient Pharmaceuticals Inc., a Denver-based specialty pharma acquisition platform sponsored by GTCR, has acquired six on-marketl products from a subsidiary of Belgium's UCB SA. No financial terms were disclosed.

30 July 2010•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles